These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24151433)

  • 1. Interaction of RAS activation and lipid disorders accelerates the progression of glomerulosclerosis.
    Ma KL; Ni J; Wang CX; Liu J; Zhang Y; Wu Y; Lv LL; Ruan XZ; Liu BC
    Int J Med Sci; 2013; 10(12):1615-24. PubMed ID: 24151433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid disorder and intrahepatic renin-angiotensin system activation synergistically contribute to non-alcoholic fatty liver disease.
    Wu Y; Ma KL; Zhang Y; Wen Y; Wang GH; Hu ZB; Liu L; Lu J; Chen PP; Ruan XZ; Liu BC
    Liver Int; 2016 Oct; 36(10):1525-34. PubMed ID: 27028410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect and mechanism of the Ang-(1-7) on human mesangial cells injury induced by low density lipoprotein.
    Huang W; Tang L; Cai Y; Zheng Y; Zhang L
    Biochem Biophys Res Commun; 2014 Jul; 450(2):1051-7. PubMed ID: 24978313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of dysregulation of low-density lipoprotein receptor expression in HepG2 cells induced by inflammatory cytokines.
    Chen YX; Ruan XZ; Huang AL; Li Q; Moorhead JF; Varghese Z
    Chin Med J (Engl); 2007 Dec; 120(24):2185-90. PubMed ID: 18167199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced glycation end products (AGEs) increase human mesangial foam cell formation by increasing Golgi SCAP glycosylation in vitro.
    Yuan Y; Zhao L; Chen Y; Moorhead JF; Varghese Z; Powis SH; Minogue S; Sun Z; Ruan XZ
    Am J Physiol Renal Physiol; 2011 Jul; 301(1):F236-43. PubMed ID: 21511699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory stress exacerbates lipid accumulation and podocyte injuries in diabetic nephropathy.
    Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Lu J; Zhang XL; Liu BC
    Acta Diabetol; 2015 Dec; 52(6):1045-56. PubMed ID: 25896009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of mTOR modulates SREBP-2 to induce foam cell formation through increased retinoblastoma protein phosphorylation.
    Ma KL; Liu J; Wang CX; Ni J; Zhang Y; Wu Y; Lv LL; Ruan XZ; Liu BC
    Cardiovasc Res; 2013 Dec; 100(3):450-60. PubMed ID: 24068000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SREBP-1 Mediates Angiotensin II-Induced TGF-β1 Upregulation and Glomerular Fibrosis.
    Wang TN; Chen X; Li R; Gao B; Mohammed-Ali Z; Lu C; Yum V; Dickhout JG; Krepinsky JC
    J Am Soc Nephrol; 2015 Aug; 26(8):1839-54. PubMed ID: 25398788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High glucose induces activation of the local renin‑angiotensin system in glomerular endothelial cells.
    Peng H; Xing YF; Ye ZC; Li CM; Luo PL; Li M; Lou TQ
    Mol Med Rep; 2014 Feb; 9(2):450-6. PubMed ID: 24337709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycation end products (AGEs) increase renal lipid accumulation: a pathogenic factor of diabetic nephropathy (DN).
    Yuan Y; Sun H; Sun Z
    Lipids Health Dis; 2017 Jun; 16(1):126. PubMed ID: 28659153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes.
    Wang Z; Jiang T; Li J; Proctor G; McManaman JL; Lucia S; Chua S; Levi M
    Diabetes; 2005 Aug; 54(8):2328-35. PubMed ID: 16046298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difference in LDL receptor feedback regulation in macrophages and vascular smooth muscle cells: foam cell transformation under inflammatory stress.
    Ye Q; Lei H; Fan Z; Zheng W; Zheng S
    Inflammation; 2014 Apr; 37(2):555-65. PubMed ID: 24297394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effects of failure of low density lipoprotein receptor expression induced by inflammation on radial artery foam cell formation in patients with end-stage renal disease].
    Ma KL; Liu J; Gao M; Ni J; Zhang Y; Zhang XL; Liu H; Huang HQ; Chen L; Wang YL; Liu BC
    Zhonghua Nei Ke Za Zhi; 2013 Jun; 52(6):464-8. PubMed ID: 24059991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirolimus modifies cholesterol homeostasis in hepatic cells: a potential molecular mechanism for sirolimus-associated dyslipidemia.
    Ma KL; Ruan XZ; Powis SH; Chen Y; Moorhead JF; Varghese Z
    Transplantation; 2007 Oct; 84(8):1029-36. PubMed ID: 17989609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of low-density lipoprotein receptor contributes to podocyte injuries in diabetic nephropathy.
    Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Liu BC
    Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1140-8. PubMed ID: 25921580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced SCAP glycosylation by inflammation induces macrophage foam cell formation.
    Zhou C; Lei H; Chen Y; Liu Q; Li LC; Moorhead JF; Varghese Z; Ruan XZ
    PLoS One; 2013; 8(10):e75650. PubMed ID: 24146768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulation of the Low-Density Lipoprotein Receptor Pathway Is Involved in Lipid Disorder-Mediated Organ Injury.
    Zhang Y; Ma KL; Ruan XZ; Liu BC
    Int J Biol Sci; 2016; 12(5):569-79. PubMed ID: 27019638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of the renin-angiotensin system ameliorates apelin production in 3T3-L1 adipocytes.
    Hung WW; Hsieh TJ; Lin T; Chou PC; Hsiao PJ; Lin KD; Shin SJ
    Cardiovasc Drugs Ther; 2011 Feb; 25(1):3-12. PubMed ID: 21161354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sterol-sensing endoplasmic reticulum (ER) membrane protein TRC8 hampers ER to Golgi transport of sterol regulatory element-binding protein-2 (SREBP-2)/SREBP cleavage-activated protein and reduces SREBP-2 cleavage.
    Irisawa M; Inoue J; Ozawa N; Mori K; Sato R
    J Biol Chem; 2009 Oct; 284(42):28995-9004. PubMed ID: 19706601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renoprotective effect of myricetin restrains dyslipidemia and renal mesangial cell proliferation by the suppression of sterol regulatory element binding proteins in an experimental model of diabetic nephropathy.
    Kandasamy N; Ashokkumar N
    Eur J Pharmacol; 2014 Nov; 743():53-62. PubMed ID: 25240712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.